Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza vs Components in Glaucoma/OHT
NCT01309204Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- May 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started May 2011; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01309204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309204.